Addex Shareholders Approve All Board Proposals at Annual General Meeting
May 09, 2012 13:11 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 9 May 2012 - Addex...
Addex Reports Positive Preclinical Data for GABA-BR PAM Oral Small Molecule in Overactive Bladder
April 16, 2012 01:00 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Program on track for IND filing before end of 2012 ...
Addex Takes Steps to Rightsize Operations and Position the Company for Future Success
April 13, 2012 12:00 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, April 13, 2012 - Addex...
Addex Reports Positive Top Line Phase IIa Data for Dipraglurant in Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID)
March 21, 2012 13:00 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} All key objectives achieved Safety and tolerability...
Addex Changes Name to Addex Therapeutics, Launches New Website and Corporate Branding
March 21, 2012 02:30 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 21 March 2012 - Addex...
Addex Pharmaceuticals Reports 2011 Financial Results
February 23, 2012 01:00 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Financial Highlights Cash and cash equivalents of...
Addex Pharmaceuticals 2011 Financial Results This Thursday
February 21, 2012 12:00 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, 21 February 2012 - Addex...
Addex to Present at the BIO CEO & Investor Conference
February 10, 2012 01:00 ET
|
Addex Therapeutics
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px; border-color:black;} Geneva, Switzerland, February 10, 2012 - Addex...
Addex: Better Tolerated Formulation of ADX10059 Reduces Acid Reflux
September 10, 2008 01:00 ET
|
Addex Therapeutics
Second trial showing mGluR5 inhibition reduces reflux in humans
Side effects dramatically reduced by formulation
Twice-daily oral dosing achieved
Doses selected for Phase IIb trials
Phase...
Disclosure of Shareholdings in Accordance with Stock Market Rules
August 07, 2008 12:00 ET
|
Addex Therapeutics
Geneva, Switzerland, 7 August 2008 - Addex Pharmaceuticals (SWX:ADXN) announced today that on August 6, 2008, Varuma AG, Aeschenvorstadt 55, 4051 Basel, Switzerland, has informed of exceeding the...